Piperlongumine Inhibits Akt Phosphorylation to Reverse Resistance to Cisplatin in Human Non-Small Cell Lung Cancer Cells via ROS Regulation
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Piperlongumine Inhibits Akt Phosphorylation to Reverse Resistance to Cisplatin in Human Non-Small Cell Lung Cancer Cells via ROS Regulation
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-10-11
DOI
10.3389/fphar.2019.01178
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Piperlongumine and p53-reactivator APR-246 selectively induce cell death in HNSCC by targeting GSTP1
- (2018) Wei Hang et al. ONCOGENE
- BRM270 inhibits cancer stem cell maintenance via microRNA regulation in chemoresistant A549 lung adenocarcinoma cells
- (2018) Taeho Kwon et al. Cell Death & Disease
- Personalized medicine in non-small cell lung cancer: A review from a pharmacogenomics perspective
- (2018) Wenxiao Jiang et al. Acta Pharmaceutica Sinica B
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Reactive Oxygen and Nitrogen Species–Induced Protein Modifications: Implication in Carcinogenesis and Anticancer Therapy
- (2018) Nurbubu T. Moldogazieva et al. CANCER RESEARCH
- Discovery of a small-molecule inhibitor of specific serine residue BAD phosphorylation
- (2018) Vijay Pandey et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lung cancer: current therapies and new targeted treatments
- (2017) Fred R Hirsch et al. LANCET
- ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway
- (2017) Yang Zhao et al. Molecular Cancer
- Association of Delayed Adjuvant Chemotherapy With Survival After Lung Cancer Surgery
- (2017) Michelle C. Salazar et al. JAMA Oncology
- Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer
- (2016) Peng Zou et al. CANCER LETTERS
- Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer
- (2016) D.A. Fennell et al. CANCER TREATMENT REVIEWS
- Historical Spice as a Future Drug: Therapeutic Potential of Piperlongumine
- (2016) Sahdeo Prasad et al. CURRENT PHARMACEUTICAL DESIGN
- FoxO3 inactivation promotes human cholangiocarcinoma tumorigenesis and chemoresistance through Keap1-Nrf2 signaling
- (2016) Li Guan et al. HEPATOLOGY
- Piperlongumine for Enhancing Oral Bioavailability and Cytotoxicity of Docetaxel in Triple-Negative Breast Cancer
- (2015) Ketan Patel et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Piperlongumine reverses doxorubicin resistance through the PI3K/Akt signaling pathway in K562/A02 human leukemia cells
- (2015) QINGWEI KANG et al. Experimental and Therapeutic Medicine
- Piperlongumine selectively kills cancer cells and increases cisplatin antitumor activity in head and neck cancer
- (2015) Jong-Lyel Roh et al. Oncotarget
- The role of DNA repair pathways in cisplatin resistant lung cancer
- (2014) Shane O’Grady et al. CANCER TREATMENT REVIEWS
- Piperlongumine Chemosensitizes Tumor Cells through Interaction with Cysteine 179 of I B Kinase, Leading to Suppression of NF- B-Regulated Gene Products
- (2014) J. G. Han et al. MOLECULAR CANCER THERAPEUTICS
- Piperlongumine Induces Apoptosis and Synergizes with Cisplatin or Paclitaxel in Human Ovarian Cancer Cells
- (2014) Li-Hua Gong et al. Oxidative Medicine and Cellular Longevity
- Mitochondria-mediated apoptosis in mammals
- (2014) Shunbin Xiong et al. Protein & Cell
- An Improved Quantitative Approach for the Assessment of Mitochondrial Fragmentation in Chemoresistant Ovarian Cancer Cells
- (2013) Lee Farrand et al. PLoS One
- Evading apoptosis in cancer
- (2013) Kaleigh Fernald et al. TRENDS IN CELL BIOLOGY
- Piperlongumine induces autophagy by targeting p38 signaling
- (2013) Y Wang et al. Cell Death & Disease
- Synthesis, cellular evaluation, and mechanism of action of piperlongumine analogs
- (2012) D. J. Adams et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Modification of Akt2 by 4-Hydroxynonenal Inhibits Insulin-Dependent Akt Signaling in HepG2 Cells
- (2011) C. T. Shearn et al. BIOCHEMISTRY
- Akt1 deletion prevents lung tumorigenesis by mutant K-ras
- (2011) M C Hollander et al. ONCOGENE
- Resveratrol Suppresses Constitutive Activation of AKT via Generation of ROS and Induces Apoptosis in Diffuse Large B Cell Lymphoma Cell Lines
- (2011) Azhar R. Hussain et al. PLoS One
- PH Domain-Only Protein PHLDA3 Is a p53-Regulated Repressor of Akt
- (2009) Tatsuya Kawase et al. CELL
- Reversal effect of tyroservatide (YSV) tripeptide on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU
- (2008) Lin-xi Shi et al. CANCER LETTERS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now